EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection

Alessa Fischer iD, Hanna Remde iD, Christina Pamporaki iD, Antonio Prinzi, Otilia Kimpel iD, Sarah Küppers, Constanze Hantel iD, Karel Pacak iD, Ashley B Grossman iD, Felix Beuschlein iD, Martin Fassnacht iD, Svenja Nölting iD

European Journal of Endocrinology · 2026

DOI: 10.1093/ejendo/lvag003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2026. Verfasst von Alessa Fischer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), and University of Zurich (UZH), Zurich CH-8091, Sw…. Hauptthemen laut MEDLINE: Quality of Life, Pheochromocytoma, Paraganglioma, Adrenal Gland Neoplasms. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Wilhelm Sander Foundation, Young Talents in Clinical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Pheochromocytomas and paragangliomas (PPGL) are rare endocrine tumors with high heritability. Carriers of pathogenic variants (PVs) in susceptibility genes face a lifelong risk of recurrence or metastatic disease. Quality of life (QoL) in patients with PPGL, a history of PPGL and PV carriers, remains insufficiently studied.

Methods

We assessed patient-reported QoL in patients with PPGL before and after surgery and in carriers of susceptibility PVs for the development of PPGLs within the prospective ProsPheo study. QoL was evaluated using standardized questionnaires (SF-12, PHQ-D, and GAD-7).

Results

A total of 202 participants were analyzed. SF-12 physical component summary scores (PCS) differed significantly across subgroups (P = .006), with the lowest PCS scores in patients with metastatic PPGL (40.3) and unresected head and neck paragangliomas (HNPGL) (40.0), compared with PV carriers after curative PPGL resection (50.2). Within metastatic disease, hormonally active tumors showed lower PCS scores than inactive tumors (36.9 vs 46.2; P = .03). Perceived physical health in carriers of a PV without history of a PPGL was significantly lower compared to the age-matched general population. Mental health was not significantly impaired across all subgroups. Clinically relevant anxiety was reported in 15.2% of PV carriers and 21.7% of patients with unresected HNPGLs, compared with about 5.9% in the general population.

Conclusions

Patient-reported physical health was reduced in patients with metastatic PPGLs, unresected HNPGLs, and PV carriers without prior PPGL, whereas patients after curative PPGL resection reported QoL comparable to the general population, regardless of PV status, suggesting that annual follow-up has minimal impact on QoL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifePheochromocytomaParagangliomaAdrenal Gland NeoplasmsHumansFemaleMiddle AgedMaleAdultProspective StudiesAgedGenetic Predisposition to Disease

Stichwörter der Autor:innen

HNPGLPPGLanxietyquality of life

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ), and University of Zurich (UZH), Zurich CH-8091, Switzerland.
  • Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Wurzburg 97080, Germany.
  • Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden 01307, Germany.
  • Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Catania 95122, Italy.
  • Center for Adrenal Endocrine Tumors, AKESO, Prague 5 155 00, Czech Republic.
  • Green Templeton College, University of Oxford, Oxford OX2 6HG, United Kingdom.

ORCID-Profile: Alessa Fischer, Hanna Remde, Christina Pamporaki, Otilia Kimpel, Constanze Hantel, Karel Pacak, Ashley B Grossman, Felix Beuschlein, Martin Fassnacht, Svenja Nölting

Förderung

  • German Research Foundation
  • Wilhelm Sander Foundation
  • Young Talents in Clinical Research
  • Swiss Academy of Medical Sciences
  • G. & J. Bangerter-Rhyner Foundation, Switzerland

Zitieren

APA

Fischer, A., Remde, H., Pamporaki, C., Prinzi, A., Kimpel, O., Küppers, S., Hantel, C., Pacak, K., Grossman, A. B., Beuschlein, F., Fassnacht, M., & Nölting, S. (2026). Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag003

Vancouver

Fischer A, Remde H, Pamporaki C, Prinzi A, Kimpel O, Küppers S, et al. Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection. European Journal of Endocrinology. 2026. doi:10.1093/ejendo/lvag003

BibTeX
@article{Fischer2026,
  author = {Fischer, Alessa and Remde, Hanna and Pamporaki, Christina and Prinzi, Antonio and Kimpel, Otilia and Küppers, Sarah and Hantel, Constanze and Pacak, Karel and Grossman, Ashley B and Beuschlein, Felix and Fassnacht, Martin and Nölting, Svenja},
  title = {Quality of life in patients with pheochromocytoma and paraganglioma: influence of tumor type, genetics and surgical resection},
  journal = {European Journal of Endocrinology},
  year = {2026},
  doi = {10.1093/ejendo/lvag003}
}
Kostenlos starten →